INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 70 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $844,000 | +15.0% | 49,421 | -8.0% | 0.00% | 0.0% |
| Q4 2018 | $734,000 | -76.9% | 53,747 | -51.6% | 0.00% | 0.0% |
| Q3 2018 | $3,180,000 | +90.1% | 111,134 | +81.8% | 0.00% | 0.0% |
| Q2 2018 | $1,673,000 | +113.7% | 61,133 | +64.6% | 0.00% | 0.0% |
| Q1 2018 | $783,000 | +0.8% | 37,147 | -8.1% | 0.00% | 0.0% |
| Q4 2017 | $777,000 | -18.5% | 40,415 | +5.4% | 0.00% | 0.0% |
| Q3 2017 | $953,000 | -14.1% | 38,339 | -44.7% | 0.00% | 0.0% |
| Q2 2017 | $1,110,000 | +302.2% | 69,349 | +253.9% | 0.00% | – |
| Q1 2017 | $276,000 | -17.1% | 19,595 | -22.9% | 0.00% | – |
| Q4 2016 | $333,000 | -5.9% | 25,420 | +22.1% | 0.00% | – |
| Q3 2016 | $354,000 | -17.7% | 20,814 | +3.4% | 0.00% | – |
| Q2 2016 | $430,000 | – | 20,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |